CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-31 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −6,250 | 56,250 | ||
| 2017-03-31 | THERO JOHN F President and CEO | Option exercise | +37,500 | 1,097,199 | ||
| 2017-03-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −15,732 | $3.20 | $50K | 1,081,467 |
| 2017-03-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −37,500 | 337,500 | ||
| 2017-02-01 | THERO JOHN F President and CEO | Grant or award · Stock Option (right to buy) | +550,000 | $2.95 | $1.6M | 550,000 |
| 2017-02-01 | Ketchum Steven B Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +133,000 | $2.95 | $392K | 133,000 |
| 2017-02-01 | Kennedy Joseph T General Counsel | Grant or award · Stock Option (right to buy) | +165,000 | $2.95 | $487K | 165,000 |
| 2017-02-01 | Kalb Michael Wayne SVP and CFO | Grant or award · Stock Option (right to buy) | +133,000 | $2.95 | $392K | 133,000 |
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise | +169,500 | 911,417 | ||
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise | +260,000 | 1,171,417 | ||
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise | +120,000 | 1,291,417 | ||
| 2017-01-31 | THERO JOHN F President and CEO | Shares withheld for taxes | −231,718 | $2.97 | $688K | 1,059,699 |
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −169,500 | 0 | ||
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −260,000 | 260,000 | ||
| 2017-01-31 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −120,000 | 240,000 | ||
| 2017-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +56,500 | 187,907 | ||
| 2017-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +60,938 | 248,845 | ||
| 2017-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +26,667 | 275,512 | ||
| 2017-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −70,236 | $2.97 | $209K | 205,276 |
| 2017-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −56,500 | 0 |
Page 91 of 95 · 1,885 trades